- Country: Brazil
- Summary: Price Registration, Aiming at Future and Eventual Purchases of High-Cost Oncological Drugs - 2023 Annual Plan.
- BRT Ref No: 82151845
- Deadline: 09 May 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 80/2023
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Purpose: Electronic Auction - Price registration, aiming at future and possible purchases of high-cost oncological drugs - annual plan 2023
Submission of the Proposal: from 04/25/2023 at 08:00 AM
ZOLEDRONIC ACID, CO492584800e8c8d91eb93b064ebe674ebNCENTRATION 4 MG, PHARMACEUTICAL FORM LIOPHIL POWDER FOR INJECTION
Amount : 5000
ANAGRELIDE HYDROCHLORIDE, DOSAGE 0.5 MG
Amount : 30000
AZACITIDINE, CONCENTRATION 100 MG, PHARMACEUTICAL FORM LIOPHILLE POWDER FOR INJECTION
Amount : 3000
BLEOMYCIN SULFATE, CONCENTRATION 15 U, PHARMACEUTICAL FORM LYOPHIL POWDER P492584800e8c8d91eb93b064ebe674eb/ INJECTABLE
Amount : 400
BORTEZOMIB, CONCENTRATION 3.5 MG, INJECTABLE PRESENTATION
Amount : 3200
CLADRIBINE, CONCENTRATION 1 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Amount : 50
DEXRAZOXANE, DOSAGE 500 MG, PHARMACEUTICAL FORM INJECTABLE
Quantity : 1000
DOXORUBICIN HYDRODRATE, CONCENT492584800e8c8d91eb93b064ebe674ebRATION 2 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity : 1500
ERLOTINIB, DOSAGE 150 MG
Quantity : 6000
FULVESTRANT, DOSAGE 50 MG/ML, PHARMACEUTICAL FORM INJECTED SOLUTION, ADDITIONAL CHARACTERISTICS 1 SYRINGE FILLED
Quantity : 1000
GEFITINIB CONCENTRATION 250 MG
Amount : 4000492584800e8c8d91eb93b064ebe674eb
IMMUNOGLOBULIN ANTI-HUMAN THYMOCYTES, RABBIT TYPE, CONCENTRATION 25 MG, PHARMACEUTICAL FORM POWDER LYOPHIL FOR INJECTION
Amount : 150
MITOTANE, CONCENTRATION 500 MG
Amount : 3000
NILOTINIB, CONCENTRATION 200 MG
Amount : 6000
OCTREOTIDE OCTREOTIDE, COMPOSITION SALT ACTREOTIDE , CONCENTRATION 20 MG, PHARMACEUTICAL FORM492584800e8c8d91eb93b064ebe674ebCEUTICA LYOPHIL POWDER FOR INJECTION, ADDITIONAL CHARACTERISTICS W/ APPLICATION SYSTEM
Quantity: 200
OCTREOTIDE, COMPOSITION ACETATE SALT, CONCENTRATION 30 MG, PHARMACEUTICAL FORM W/ LYOPHIL Powder FOR INJECTION, ADDITIONAL CHARACTERISTICS W/ APPLICATION SYSTEM
Quantity: 400
PAZOPANIB , CONCENTRATION 400 MG
Wed492584800e8c8d91eb93b064ebe674ebEntity : 8000
PEGASPARGASE, CONCENTRATION 750 U/... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPrice Registration, Aiming at Future and Eventual Purchases of High-Cost Oncological Drugs - 2023 Annual Plan. - Brazil Tender
The STATE HEALTH FUND, a Government sector organization in Brazil, has announced a new tender for Price Registration, Aiming at Future and Eventual Purchases of High-Cost Oncological Drugs - 2023 Annual Plan.. This tender is published on BrazilTenders under BRT Ref No: 82151845 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-05-09.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
